Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using the patient's own T-cells to target tumors.

In October 2024, FCB goalkeeper Mala Grohs was diagnosed with cancer. Now, just over a year later, she’s not only fit as a ...

The recent deaths of three hikers have drawn attention to Mt. Baldy's double-sided nature, particularly the exposed-ridgeline ...

Women’s health is understudied and, in many respects, poorly understood. Even the term “women’s health” is often used as a ...

The HBO Max drama immerses viewers in the struggles faced by the ER staff at the fictional Pittsburgh Trauma Medical Center. ...

A new study published in Science Translational Medicine has demonstrated a new mechanism by which mRNA COVID vaccines can ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

Heston Kjerstad went through an extended period of uncertainty after the Orioles made him the second overall pick in the 2020 ...

Stanford researchers have identified a biological pathway that helps explain why mRNA COVID-19 vaccines can, in very rare ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

One of the most widely known risks linked to the COVID-19 vaccine is myocarditis, especially in young males — and now a new Stanford study has shed some light on why this rare effect can occur.